文献速递神经外科与老年麻醉

阿尔茨海默病生物标志物与术后谵妄或认知功能障碍的关联:前瞻性临床试验的荟萃分析与试验序贯分析

Associations between Alzheimer's disease biomarkers and postoperative delirium or cognitive dysfunction: A meta-analysis and trial sequential analysis of prospective clinical trials.
PubMed 文献 · Eur J Anaesthesiol · 2023-12-01

该荟萃分析纳入15项观察性临床研究,评估围术期阿尔茨海默病生物标志物与术后谵妄(POD)或术后认知功能障碍(POCD)的关联。结果显示术前脑脊液β-淀粉样蛋白42(Aβ42)水平与POD和POCD均呈负相关,试验序贯分析支持该关联;其他生物标志物的证据尚不充分。

要点

  • 术前脑脊液Aβ42水平与POD发生呈负相关(均值差-86.1)。
  • 术前脑脊液Aβ42水平与POCD发生也呈负相关(均值差-165.01)。
  • 其他生物标志物与POD或POCD的关联证据尚不充分。

核心结论

  • 术前脑脊液Aβ42水平与POD和POCD的发生均呈负相关。
  • 其他阿尔茨海默病生物标志物与POD或POCD的关联证据尚不充分。

研究设计与样本

  • 遵循PRISMA指南的荟萃分析,方案已注册(INPLASY202350001)。
  • 检索PubMed、Embase、Web of Science和Cochrane数据库至2023年3月。
  • 纳入15项观察性临床研究,其中6项关注POD,9项关注POCD。
  • 纳入标准为年龄至少18岁的手术患者,研究POD或POCD,涉及血液或脑脊液中的Aβ或tau生物标志物,并可获取全文。

主要发现

  • 术前脑脊液Aβ42水平与POD发生呈负相关(均值差-86.1,95%CI -114.15至-58.05,I²=47%),试验序贯分析强烈支持该关联。
  • 术前脑脊液Aβ42水平与POCD发生呈负相关(均值差-165.01,95%CI -261.48至-68.53,I²=95%),试验序贯分析提供稳健证据。
  • 证据不足以确认其他阿尔茨海默病生物标志物(Aβ40、总tau、磷酸化tau、Aβ42/总tau比值)与POD或POCD的关联。

临床怎么用

  • 术前脑脊液Aβ42水平可能有助于识别POD和POCD高风险患者。
  • 其他阿尔茨海默病生物标志物目前尚不能用于预测POD或POCD。

局限性

  • 未来研究需要确定术前脑脊液Aβ42预测POD和POCD的截断值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The relationship between Alzheimer's disease biomarkers and postoperative complications, such as postoperative delirium (POD) and postoperative cognitive dysfunction (POCD), remains a subject of ongoing debate. OBJECTIVE: This meta-analysis aimed to determine whether there is an association between perioperative Alzheimer's disease biomarkers and postoperative complications. DESIGN: We conducted a meta-analysis of observational clinical studies that explored the correlation between Alzheimer's disease biomarkers and POD or POCD in patients who have undergone surgery, following PRISMA guidelines. The protocol was previously published (INPLASY: INPLASY202350001). DATA SOURCES: A comprehensive search was conducted across PubMed, Embase, Web of Science, and Cochrane databases until March 2023. ELIGIBILITY CRITERIA: Surgical patients aged at least 18 years, studies focusing on POD or POCD, research involving Alzheimer's disease biomarkers, including Aβ or tau in blood or cerebrospinal fluid (CSF), and availability of the full text. RESULTS: Our meta-analysis included 15 studies: six focusing on POD and nine on POCD. The findings revealed a negative correlation between preoperative CSF β-amyloid 42 (Aβ42) levels and the onset of POD [mean difference -86.1, 95% confidence interval (CI), -114.15 to -58.05, I2 : 47%]; this association was strongly supported by trial sequential analysis (TSA). A similar negative correlation was discerned between preoperative CSF Aβ42 levels and the incidence of POCD (-165.01, 95% CI, -261.48 to -68.53, I2 : 95%). The TSA also provided robust evidence for this finding; however, the evidence remains insufficient to confirm a relationship between other Alzheimer's disease biomarkers [β-amyloid 40 (Aβ40), total tau (T-tau), phosphorylated tau (P-tau), and Aβ42/T-tau ratio] and POD or POCD. CONCLUSION: The study results indicate a negative correlation between preoperative CSF Aβ42 levels and the occurrence of both POD and POCD. Future investigations are warranted to identify the predictive cutoff value of preoperative CSF Aβ42 for POD and POCD.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Geng J, Zhang Y, Chen H, et al. Associations between Alzheimer's disease biomarkers and postoperative delirium or cognitive dysfunction: A meta-analysis and trial sequential analysis of prospective clinical trials. Eur J Anaesthesiol. 2023. PMID: 38038408. doi:10.1097/EJA.0000000000001933

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。